Integration of retroviruses: A fine balance between efficiency and danger

被引：24

作者：

Fischer, A ^{[1
]}

Cavazzana-Calvo, M

机构：

[1] Necker Univ Hosp, INSERM, Dept Pediat Immunol, Paris, France

[2] Necker Univ Hosp, INSERM, Res Unit 429, Paris, France

[3] Necker Univ Hosp, Biotherapy Dept, Paris, France

来源：

PLOS MEDICINE | 2005年 / 2卷 / 01期

关键词：

D O I：

10.1371/journal.pmed.0020010

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：22 / 24

页数：3

共 10 条

[1] Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning [J].

Aiuti, A ;

Slavin, S ;

Aker, M ;

Ficara, F ;

Deola, S ;

Mortellaro, A ;

Morecki, S ;

Andolfi, G ;

Tabucchi, A ;

Carlucci, F ;

Marinello, E ;

Cattaneo, F ;

Vai, S ;

Servida, P ;

Miniero, R ;

Roncarolo, MG ;

Bordignon, C .

SCIENCE, 2002, 296 (5577) :2410-2413

[2] Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease [J].

Cavazzana-Calvo, M ;

Hacein-Bey, S ;

Basile, CD ;

Gross, F ;

Yvon, E ;

Nusbaum, P ;

Selz, F ;

Hue, C ;

Certain, S ;

Casanova, JL ;

Bousso, P ;

Le Deist, F ;

Fischer, A .

SCIENCE, 2000, 288 (5466) :669-672

[3]

Coffin J. M., 1997, RETROVIRUSES

[4] LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 [J].

Hacein-Bey-Abina, S ;

Von Kalle, C ;

Schmidt, M ;

McCcormack, MP ;

Wulffraat, N ;

Leboulch, P ;

Lim, A ;

Osborne, CS ;

Pawliuk, R ;

Morillon, E ;

Sorensen, R ;

Forster, A ;

Fraser, P ;

Cohen, JI ;

de Saint Basile, G ;

Alexander, I ;

Wintergerst, U ;

Frebourg, T ;

Aurias, A ;

Stoppa-Lyonnet, D ;

Romana, S ;

Radford-Weiss, I ;

Gross, F ;

Valensi, F ;

Delabesse, E ;

Macintyre, E ;

Sigaux, F ;

Soulier, J ;

Leiva, LE ;

Wissler, M ;

Prinz, C ;

Rabbitts, TH ;

Le Deist, F ;

Fischer, A ;

Cavazzana-Calvo, M .

SCIENCE, 2003, 302 (5644) :415-419

[5] Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells [J].

Hematti, P ;

Hong, BK ;

Ferguson, C ;

Adler, R ;

Hanawa, H ;

Sellers, S ;

Holt, IE ;

Eckfeldt, CE ;

Sharma, Y ;

Schmidt, M ;

von Kalle, C ;

Persons, DA ;

Billings, EM ;

Verfaillie, CM ;

Nienhuis, AW ;

Wolfsberg, TG ;

Dunbar, CE ;

Calmels, B .

PLOS BIOLOGY, 2004, 2 (12) :2183-2190

[6] Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cells [J].

Laufs, S ;

Gentner, B ;

Nagy, KZ ;

Jauch, A ;

Benner, A ;

Naundorf, S ;

Kuehlcke, K ;

Schiedlmeier, B ;

Ho, AD ;

Zeller, WJ ;

Fruehauf, S .

BLOOD, 2003, 101 (06) :2191-2198

[7] Murine leukemia induced by retroviral gene marking [J].

Li, ZX ;

Düllmann, J ;

Schiedlmeier, B ;

Schmidt, M ;

von Kalle, C ;

Meyer, J ;

Forster, M ;

Stocking, C ;

Wahlers, A ;

Frank, O ;

Ostertag, W ;

Kühlcke, K ;

Eckert, HG ;

Fehse, B ;

Baum, C .

SCIENCE, 2002, 296 (5567) :497-497

[8] Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences [J].

Mitchell, RS ;

Beitzel, BF ;

Schroder, ARW ;

Shinn, P ;

Chen, HM ;

Berry, CC ;

Ecker, JR ;

Bushman, FD .

PLOS BIOLOGY, 2004, 2 (08) :1127-1137

[9] HIV-1 integration in the human genome favors active genes and local hotspots [J].

Schröder, ARW ;

Shinn, P ;

Chen, HM ;

Berry, C ;

Ecker, JR ;

Bushman, F .

CELL, 2002, 110 (04) :521-529

[10] Transcription start regions in the human genome are favored targets for MLV integration [J].

Wu, XL ;

Li, Y ;

Crise, B ;

Burgess, SM .

SCIENCE, 2003, 300 (5626) :1749-1751

← 1 →